Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting (NCT07378839) | Clinical Trial Compass
RecruitingNot Applicable
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
United States100 participantsStarted 2026-02-10
Plain-language summary
This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pregnant individuals aged 18 years or older
* Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks of gestation, confirmed by last menstrual period or ultrasound
* Diagnosed with mild to moderate NVP (PUQE-24 score between 4-12)
* Ability to understand and read English
Exclusion Criteria:
* Severe nausea and vomiting, defined as a PUQE score \>12, or diagnosis of hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy
* Pre-existing, active or acute respiratory conditions (e.g., asthma, COPD)
* History of severe anxiety disorders affecting breathing patterns
* Known deviated nasal septum
* Nausea and vomiting that pre-dates the pregnancy or is suspected to be due to a etiology other than pregnancy